ES2069970T3 - Utilizacion de la pirrolidona carboxilato de lisina y/o de arginina como substancia antioxidante en una composicion cosmetica o farmaceutica. - Google Patents

Utilizacion de la pirrolidona carboxilato de lisina y/o de arginina como substancia antioxidante en una composicion cosmetica o farmaceutica.

Info

Publication number
ES2069970T3
ES2069970T3 ES92401189T ES92401189T ES2069970T3 ES 2069970 T3 ES2069970 T3 ES 2069970T3 ES 92401189 T ES92401189 T ES 92401189T ES 92401189 T ES92401189 T ES 92401189T ES 2069970 T3 ES2069970 T3 ES 2069970T3
Authority
ES
Spain
Prior art keywords
arginine
cosmetic
lyrine
pirrolidone
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92401189T
Other languages
English (en)
Spanish (es)
Inventor
Guyen Lan Quang N
Etienne Soudant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2069970T3 publication Critical patent/ES2069970T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES92401189T 1991-04-24 1992-04-24 Utilizacion de la pirrolidona carboxilato de lisina y/o de arginina como substancia antioxidante en una composicion cosmetica o farmaceutica. Expired - Lifetime ES2069970T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105062A FR2675692A1 (fr) 1991-04-24 1991-04-24 Systeme anti-oxydant contenant du pyrrolidone carboxylate de lysine et/ou du pyrrolidone carboxylate d'arginine soit seul soit associe a un derive phenolique et son utilisation en cosmetique.

Publications (1)

Publication Number Publication Date
ES2069970T3 true ES2069970T3 (es) 1995-05-16

Family

ID=9412210

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92401189T Expired - Lifetime ES2069970T3 (es) 1991-04-24 1992-04-24 Utilizacion de la pirrolidona carboxilato de lisina y/o de arginina como substancia antioxidante en una composicion cosmetica o farmaceutica.

Country Status (10)

Country Link
US (1) US5352695A (enExample)
EP (1) EP0511118B1 (enExample)
JP (1) JP3405740B2 (enExample)
AT (1) ATE119028T1 (enExample)
AU (1) AU1507692A (enExample)
CA (1) CA2066924C (enExample)
DE (1) DE69201510T2 (enExample)
DK (1) DK0511118T3 (enExample)
ES (1) ES2069970T3 (enExample)
FR (1) FR2675692A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
JP3686434B2 (ja) * 1993-10-01 2005-08-24 千寿製薬株式会社 コンタクトレンズ用剤の安定化方法
IT1286564B1 (it) * 1996-03-05 1998-07-15 Comiter Trading & Services S R Un prodotto a base di olio extravergine di oliva,olio vergine di oliva od olio di oliva arricchito ed integrato,ed un procedimento per
FR2746316B1 (fr) * 1996-03-19 1998-06-12 Guerlain Nouvelles compositions cosmetologiques ou dermatologiques
JP3497335B2 (ja) * 1996-11-12 2004-02-16 株式会社資生堂 口紅用組成物
FR2815866B1 (fr) * 2000-10-31 2015-06-19 Sephra Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes
FR2815872A1 (fr) * 2000-10-31 2002-05-03 Sephra Nouvelles compositions cosmetiques et leur utilisation pour diminuer l'adhesion des granulocytes
US6497885B2 (en) 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
ATE319503T1 (de) * 2002-05-29 2006-03-15 Unilever Nv Regulierung des geruchs von kosmetischen zusammensetzungen, welche aminsalze enthalten
EP1515688B1 (fr) 2002-06-11 2013-07-24 L'Oréal Utilisation d'un complexe salen-manganèse comme agent protecteur des mélanocytes du follicule pileux et applications cosmétiques
FR2840531B1 (fr) * 2002-06-11 2004-10-29 Oreal Composition cosmetique comprenant un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) pour lutter contre la canitie
US20040185074A1 (en) * 2003-03-17 2004-09-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Odor control in amine salt containing cosmetic compositions
WO2005084301A2 (en) 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
JP5168996B2 (ja) * 2007-04-13 2013-03-27 味の素株式会社 アミノ酸類高配合防腐水溶液
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
FR3040296B1 (fr) * 2015-09-01 2019-06-14 Usines Chimiques D'ivry La Bataille Sa Composition cosmetique et/ou dermatologique comprenant l'acide pyrrolidone carboxylate d'arginine pour lutter contre le vieillissement cutane
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
JP7412898B2 (ja) * 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP7612326B2 (ja) 2019-12-16 2025-01-14 ロレアル 特定の成分の組合せを含む安定な組成物
FR3131845B1 (fr) 2022-01-19 2024-11-01 Oreal Composition stable comprenant un rétinoïde
EP4452190A1 (en) 2021-12-20 2024-10-30 L'oreal Stable composition comprising retinoid and ascorbic acid compound
KR20240099313A (ko) 2021-12-20 2024-06-28 로레알 레티노이드를 포함하는 안정한 조성물
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
FR3145279A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition comprenant un complexe polyionique à base d’acide hyaluronique et un antioxydant lipophile
WO2024135424A1 (en) 2022-12-20 2024-06-27 L'oreal Composition comprising hyaluronic acid-based polyion complex and hydrophilic or lipophilic antioxidant
FR3145278A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition de dispersion stable comprenant un rétinoïde
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid
FR3148912A1 (fr) 2023-05-24 2024-11-29 L'oreal Composition comprenant des polymères cationiques et anioniques
FR3152226B3 (fr) 2023-08-25 2025-09-19 Oreal Composition cosmétique anhydre pour une application douce et peu grasse

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671020A (en) * 1979-11-15 1981-06-13 Shiseido Co Ltd Cosmetics
JPS6130509A (ja) * 1984-07-23 1986-02-12 Shiseido Co Ltd 皮膚外用剤
IT1202426B (it) * 1987-01-26 1989-02-09 Poli Ind Chimica Spa Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
GB8821129D0 (en) * 1988-09-09 1988-10-12 Unilever Plc Cosmetic composition

Also Published As

Publication number Publication date
AU1507692A (en) 1992-10-29
FR2675692B1 (enExample) 1995-01-13
DE69201510T2 (de) 1995-07-13
JP3405740B2 (ja) 2003-05-12
CA2066924A1 (fr) 1992-10-25
JPH05271048A (ja) 1993-10-19
FR2675692A1 (fr) 1992-10-30
DK0511118T3 (da) 1995-05-01
EP0511118A1 (fr) 1992-10-28
EP0511118B1 (fr) 1995-03-01
CA2066924C (fr) 1998-10-20
DE69201510D1 (de) 1995-04-06
ATE119028T1 (de) 1995-03-15
US5352695A (en) 1994-10-04

Similar Documents

Publication Publication Date Title
ES2069970T3 (es) Utilizacion de la pirrolidona carboxilato de lisina y/o de arginina como substancia antioxidante en una composicion cosmetica o farmaceutica.
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
CA2108804A1 (fr) Composition cosmetique ou dermo-pharmaceutique contenant en association un lauroylmethionate d'un amino acide basique et au moins un polyphenol
DE69637749D1 (de) Getrocknete Blutfaktorzusammensetzung mit Trehalose
BR9403783A (pt) Uso de uma composição cosmética
NO924474L (no) Orale preparater med forbedret tannhvittende effekt
AU633714B2 (en) New uses of l-deprenyl and compositions for same
DE69007964D1 (de) Verwendung von Thrombospondin zur Beschleunigung der Wundheilung.
AU7727691A (en) Hair dye composition and its application method
FI915783A7 (fi) N-jodipropargyylioksikarbonyyliaminohappoesterit ja niiden johdannaiset sekä niiden käyttö antimikrobisina aineina
DE69023980D1 (de) 2-(RS)-substituierte-2,3-dihydro-5-oxy-4,6,7-trimethyl-benzofurane, verwendbar als antioxydante Arzneimittel mit mukoregulierender und anti-ischemischer Wirkung.
ATE369850T1 (de) Topische anwendung von vitamin e ester
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
FI934325A7 (fi) Hyönteismyrkkykoostumus ja hyönteismyrkky-yksiköitä
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
IT1240683B (it) Composizione farmaceutica contenente egf
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
ES2054029T3 (es) Formulacion de acetato de flecainida con liberacion controlada.
ES2126580T3 (es) Proteina condromodulina-ii.
DE68916275D1 (de) 1-Carbacephalosporin-Antibiotika.
DK0550783T3 (da) Anvendelse af diolestere i hunde- og kattefoder
DE59809951D1 (de) Antioxidative Zusammensetzungen mit Süssmolkekonzentrat und Casein
ES2062361T3 (es) Composicion cosmetica.
PT1108716E (pt) Derivados de taxano em c7 e composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 511118

Country of ref document: ES